UHS Stock Forecast & Price Target

Universal Health Services demonstrated strong financial performance, with its acute care segment's same-store adjusted EBITDA margin expanding by 190 basis points to 15.8%, and behavioral health revenue increasing by 9.3%. The company reported a positive trend in patient volumes, supported by a 1.3% year-over-year growth in adjusted patient days, alongside anticipated earnings benefits from programs pending CMS approval valued between $75 million and $80 million. Furthermore, the 2026 outlook indicates a favorable environment for revenue growth, as pricing remains robust while operational efficiencies are expected to further enhance margins in the coming years.

Universal Health Services faces a negative outlook due to projected volume and margin headwinds, which are expected to result in earnings approximately 5% below estimates for fiscal year 2026. The company's long-term outlook for behavioral volume has been adjusted downwards to a range of 2-3%, further impacting growth given that declines in the DPP contribution, currently accounting for 52% of EBITDA, are anticipated starting in 2028. Additional risks include high market concentration in Las Vegas, potential adverse impacts from state budget constraints on behavioral health services, and labor supply tightness affecting productivity and profit margins.